Vulvovaginal candidiasis [PDF]
International Journal of Gynecology & Obstetrics, 2006 D, Moreira, C R, Paula
openaire +4 more sources
Ливарол в лечении хронического вульвовагинального кандидоза [PDF]
, 2010 КАНДИДОЗ ...
Дивакова, Т. С. +1 more
core
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges [PDF]
, 2012 The commensal fungus Candida albicans causes mucosal candidiasis in the rapidly expanding number of immunocompromised patients. Mucosal candidiasis includes oropharyngeal, esophageal, gastrointestinal, and vaginal infections.
Gabrielli E +3 more
core +1 more source
Small Structures, Volume 6, Issue 10, October 2025.Nanozymes emerge as promising therapeutic agents for reactive oxygen species (ROS)‐dependent diseases, offering advantages over traditional biocatalysts through enhanced stability, tunability, and targeting capabilities. This review explores their mechanisms, design strategies, and clinical progress, emphasizing precision medicine potential.
Lihong Zhou +8 more
wiley +1 more source
Vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis [PDF]
Background: Vulvovaginal candidiasis (VVC) is a fungal infection of the vagina and vulva. It is usually caused by Candida albicans, however, occasionally other candida species are responsible. The optimal treatment of VVC has not yet been defined.
تلو, مهشید +3 more
core
In vitro antifungal activity of aqueous-ethanolic extract of Allium jesdianum against fluconazole-susceptible and -resistant human vaginal Candida glabrata isolates [PDF]
, 2017 Introduction: About 50 of women are diagnosed with an episode of vulvovaginal candidiasis (VVC) during first 25 years of their lives. Candida glabrata is considered the second most prevalent non-C. albicans species associated with VVC.
Balal, Asad. +6 more
core +1 more source
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis [PDF]
, 2017 Vulvovaginal candidiasis is the most prevalent vaginal infection worldwide and Candida albicans is its major agent. Vulvovaginal candidiasis is characterized by disruption of the vaginal microbiota composition, as happens following large spectrum ...
Ballet Nathalie +10 more
core +1 more source
Fundamental &Clinical Pharmacology, Volume 39, Issue 5, October 2025.ABSTRACT This review highlights the integration of drug repurposing and nanotechnology‐driven delivery strategies as innovative approaches to enhance the antifungal activity of statins against mucosal candidiasis, providing a framework for future translational research and clinical application.
Dominique Mesquita e Silva +8 more
wiley +1 more source
Logic regression-derived algorithms for syndromic management of vaginal infections. [PDF]
, 2015 BACKGROUND: Syndromic management of vaginal infections is known to have poor diagnostic accuracy. Logic regression is a machine-learning procedure which allows for the identification of combinations of variables to predict an outcome, such as the ...
Hubbard, Alan +5 more
core +4 more sources
مقايسه مصرف همزمان فلوکونازول و کلوتريمازول با دوز دنبال شونده آن در درمان و عود واژينيت کانديدايی راجعه در شهر بوشهر [PDF]
, 2009 زمينه: فلوکونازول داروی ضدقارچ سيستميک مؤثر و کلوتريمازول نيز داروی ضدقارچی موضعی عليه کانديدا آلبيکانس می باشد و روش ترکيب درمانی واژينيت کانديدايی به منظور مقايسه مصرف همزمان فلوکونازول و کلوتريمازول با دوز دنبال شونده آن در درمان واژينيت کانديدايی ...
احمدی, شهناز +7 more
core